151 related articles for article (PubMed ID: 12882323)
1. Increased p27, an essential component of cell cycle control, in Alzheimer's disease.
Ogawa O; Lee HG; Zhu X; Raina A; Harris PL; Castellani RJ; Perry G; Smith MA
Aging Cell; 2003 Apr; 2(2):105-10. PubMed ID: 12882323
[TBL] [Abstract][Full Text] [Related]
2. Phosphorylation of paired helical filament tau in Alzheimer's disease neurofibrillary lesions: focusing on phosphatases.
Trojanowski JQ; Lee VM
FASEB J; 1995 Dec; 9(15):1570-6. PubMed ID: 8529836
[TBL] [Abstract][Full Text] [Related]
3. S6 kinase phosphorylated at T229 is involved in tau and actin pathologies in Alzheimer's disease.
Sonoda Y; Tooyama I; Mukai H; Maeda K; Akiyama H; Kawamata T
Neuropathology; 2016 Aug; 36(4):325-32. PubMed ID: 26582459
[TBL] [Abstract][Full Text] [Related]
4. Enhanced proteasome-dependent degradation of the CDK inhibitor p27(kip1) in immortalized lymphocytes from Alzheimer's dementia patients.
Muñoz U; Bartolomé F; Bermejo F; Martín-Requero A
Neurobiol Aging; 2008 Oct; 29(10):1474-84. PubMed ID: 17448572
[TBL] [Abstract][Full Text] [Related]
5. Glycogen synthase kinase-3 is associated with neuronal and glial hyperphosphorylated tau deposits in Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration.
Ferrer I; Barrachina M; Puig B
Acta Neuropathol; 2002 Dec; 104(6):583-91. PubMed ID: 12410379
[TBL] [Abstract][Full Text] [Related]
6. Elevated expression of a regulator of the G2/M phase of the cell cycle, neuronal CIP-1-associated regulator of cyclin B, in Alzheimer's disease.
Zhu X; McShea A; Harris PL; Raina AK; Castellani RJ; Funk JO; Shah S; Atwood C; Bowen R; Bowser R; Morelli L; Perry G; Smith MA
J Neurosci Res; 2004 Mar; 75(5):698-703. PubMed ID: 14991845
[TBL] [Abstract][Full Text] [Related]
7. A growth factor-dependent nuclear kinase phosphorylates p27(Kip1) and regulates cell cycle progression.
Boehm M; Yoshimoto T; Crook MF; Nallamshetty S; True A; Nabel GJ; Nabel EG
EMBO J; 2002 Jul; 21(13):3390-401. PubMed ID: 12093740
[TBL] [Abstract][Full Text] [Related]
8. Expression of the cyclin-dependent kinase inhibitor p16 in Alzheimer's disease.
Arendt T; Rödel L; Gärtner U; Holzer M
Neuroreport; 1996 Nov; 7(18):3047-9. PubMed ID: 9116237
[TBL] [Abstract][Full Text] [Related]
9. Inducible expression of a degradation-resistant form of p27Kip1 causes growth arrest and apoptosis in breast cancer cells.
Zhang Q; Tian L; Mansouri A; Korapati AL; Johnson TJ; Claret FX
FEBS Lett; 2005 Jul; 579(18):3932-40. PubMed ID: 15996662
[TBL] [Abstract][Full Text] [Related]
10. Immunocytochemistry of tau phosphoserine 413 and tau protein kinase I in Alzheimer pathology.
Shiurba RA; Ishiguro K; Takahashi M; Sato K; Spooner ET; Mercken M; Yoshida R; Wheelock TR; Yanagawa H; Imahori K; Nixon RA
Brain Res; 1996 Oct; 737(1-2):119-32. PubMed ID: 8930358
[TBL] [Abstract][Full Text] [Related]
11. Active caspase-6 and caspase-6-cleaved tau in neuropil threads, neuritic plaques, and neurofibrillary tangles of Alzheimer's disease.
Guo H; Albrecht S; Bourdeau M; Petzke T; Bergeron C; LeBlanc AC
Am J Pathol; 2004 Aug; 165(2):523-31. PubMed ID: 15277226
[TBL] [Abstract][Full Text] [Related]
12. Cyclin-dependent kinase 5 immunoreactivity for granulovacuolar degeneration.
Nakamori M; Takahashi T; Yamazaki Y; Kurashige T; Yamawaki T; Matsumoto M
Neuroreport; 2012 Oct; 23(15):867-72. PubMed ID: 22968343
[TBL] [Abstract][Full Text] [Related]
13. The p53 homologue p73 accumulates in the nucleus and localizes to neurites and neurofibrillary tangles in Alzheimer disease brain.
Wilson C; Henry S; Smith MA; Bowser R
Neuropathol Appl Neurobiol; 2004 Feb; 30(1):19-29. PubMed ID: 14720173
[TBL] [Abstract][Full Text] [Related]
14. Activation of Akt/PKB, increased phosphorylation of Akt substrates and loss and altered distribution of Akt and PTEN are features of Alzheimer's disease pathology.
Griffin RJ; Moloney A; Kelliher M; Johnston JA; Ravid R; Dockery P; O'Connor R; O'Neill C
J Neurochem; 2005 Apr; 93(1):105-17. PubMed ID: 15773910
[TBL] [Abstract][Full Text] [Related]
15. Molecular dissection of the neurofibrillary lesions of Alzheimer's disease.
Goedert M
Arzneimittelforschung; 1995 Mar; 45(3A):403-9. PubMed ID: 7763334
[TBL] [Abstract][Full Text] [Related]
16. BCR signals target p27(Kip1) and cyclin D2 via the PI3-K signalling pathway to mediate cell cycle arrest and apoptosis of WEHI 231 B cells.
Banerji L; Glassford J; Lea NC; Thomas NS; Klaus GG; Lam EW
Oncogene; 2001 Nov; 20(50):7352-67. PubMed ID: 11704865
[TBL] [Abstract][Full Text] [Related]
17. Distribution, levels and phosphorylation of Raf-1 in Alzheimer's disease.
Mei M; Su B; Harrison K; Chao M; Siedlak SL; Previll LA; Jackson L; Cai DX; Zhu X
J Neurochem; 2006 Dec; 99(5):1377-88. PubMed ID: 17064357
[TBL] [Abstract][Full Text] [Related]
18. Helicobacter pylori increases proteasome-mediated degradation of p27(kip1) in gastric epithelial cells.
Eguchi H; Herschenhous N; Kuzushita N; Moss SF
Cancer Res; 2003 Aug; 63(15):4739-46. PubMed ID: 12907657
[TBL] [Abstract][Full Text] [Related]
19. Accumulation of tumor-suppressor PTEN in Alzheimer neurofibrillary tangles.
Sonoda Y; Mukai H; Matsuo K; Takahashi M; Ono Y; Maeda K; Akiyama H; Kawamata T
Neurosci Lett; 2010 Feb; 471(1):20-4. PubMed ID: 20056128
[TBL] [Abstract][Full Text] [Related]
20. Abnormal expression of the cell cycle regulators P16 and CDK4 in Alzheimer's disease.
McShea A; Harris PL; Webster KR; Wahl AF; Smith MA
Am J Pathol; 1997 Jun; 150(6):1933-9. PubMed ID: 9176387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
